VOLUME 7 (2016)
View Archive »
About The Cover
Histone H3 lysine 4 acetylation and methylation dynamics define breast cancer subtypes. See Messier et al.
Table of Contents
Editorial
|
| Molecular control of nonmuscle myosin II assembly |
|
https://doi.org/10.18632/oncotarget.6936
|
| 5092-5093 |
Priority Research Papers
|
| Histone H3 lysine 4 acetylation and methylation dynamics define breast cancer subtypes |
|
https://doi.org/10.18632/oncotarget.6922
|
| 5094-5109 |
|
| Use of HLA peptidomics and whole exome sequencing to identify human immunogenic neoantigens |
|
https://doi.org/10.18632/oncotarget.6960
|
| 5110-5117 |
Research Papers: Gerotarget (Focus on Aging)
|
| XIAPassociating factor 1 a transcriptional target of BRD7 contributes to endothelial cell senescence |
|
https://doi.org/10.18632/oncotarget.6962
|
| 5118-5130 |
Research Papers: Pathology
|
| Analysis of small nucleolar RNAs in sputum for lung cancer diagnosis |
|
https://doi.org/10.18632/oncotarget.4219
|
| 5131-5142 |
Research Papers: Immunology
|
| Ectonucleotidase activity and immunosuppression in astrocyteCD4 T cell bidirectional signaling |
|
https://doi.org/10.18632/oncotarget.6914
|
| 5143-5156 |
Research Papers: Autophagy and Cell Death
|
| Dual PI3 kinase/mTOR inhibition impairs autophagy flux and induces cell death independent of apoptosis and necroptosis |
|
https://doi.org/10.18632/oncotarget.6986
|
| 5157-5175 |
Research Papers: Chromosome
|
| Mcl1 dynamics influence mitotic slippage and death in mitosis |
|
https://doi.org/10.18632/oncotarget.6894
|
| 5176-5192 |
Reviews
|
| Bcl2 family proteins as regulators of cancer cell invasion and metastasis: a review focusing on mitochondrial respiration and reactive oxygen species |
|
https://doi.org/10.18632/oncotarget.6405
|
| 5193-5203 |
|
| A novel approach to the discovery of antitumor pharmaceuticals: searching for activators of liponecrosis |
|
https://doi.org/10.18632/oncotarget.6440
|
| 5204-5225 |
|
| Long noncoding RNAs in colorectal cancer |
|
https://doi.org/10.18632/oncotarget.6446
|
| 5226-5239 |
Research Papers
|
| Multifactorial resistance to aminopeptidase inhibitor prodrug CHR2863 in myeloid leukemia cells: downregulation of carboxylesterase 1 drug sequestration in lipid droplets and prosurvival activation ERK/Akt/mTOR |
|
https://doi.org/10.18632/oncotarget.6169
|
| 5240-5257 |
|
| Tubeimoside1 suppresses tumor angiogenesis by stimulation of proteasomal VEGFR2 and Tie2 degradation in a nonsmall cell lung cancer xenograft model |
|
https://doi.org/10.18632/oncotarget.6676
|
| 5258-5272 |
|
| Unscrambling the genomic chaos of osteosarcoma reveals extensive transcript fusion recurrent rearrangements and frequent novel TP53 aberrations |
|
https://doi.org/10.18632/oncotarget.6567
|
| 5273-5288 |
|
| VEcadherin cleavage by ovarian cancer microparticles induces βcatenin phosphorylation in endothelial cells |
|
https://doi.org/10.18632/oncotarget.6677
|
| 5289-5305 |
|
| Wholeexome tumor sequencing study in biliary cancer patients with a response to MEK inhibitors |
|
https://doi.org/10.18632/oncotarget.6632
|
| 5306-5312 |
|
| Differential expression of neurogenes among breast cancer subtypes identifies high risk patients |
|
https://doi.org/10.18632/oncotarget.6543
|
| 5313-5326 |
|
| Protein kinase D2 contributes to TNFαinduced epithelial mesenchymal transition and invasion <em>via</em> the PI3K/GSK3β/βcatenin pathway in hepatocellular carcinoma |
|
https://doi.org/10.18632/oncotarget.6633
|
| 5327-5341 |
|
| Rab23 promotes squamous cell carcinoma cell migration and invasion via integrin β1/Rac1 pathway |
|
https://doi.org/10.18632/oncotarget.6701
|
| 5342-5352 |
|
| βcatenin nuclear translocation in colorectal cancer cells is suppressed by PDE10A inhibition cGMP elevation and activation of PKG |
|
https://doi.org/10.18632/oncotarget.6705
|
| 5353-5365 |
|
| Triptolide induces protective autophagy through activation of the CaMKKβAMPK signaling pathway in prostate cancer cells |
|
https://doi.org/10.18632/oncotarget.6783
|
| 5366-5382 |
|
| Cyclin D1 silencing suppresses tumorigenicity impairs DNA double strand break repair and thus radiosensitizes androgenindependent prostate cancer cells to DNA damage |
|
https://doi.org/10.18632/oncotarget.6579
|
| 5383-5400 |
|
| Allelespecific silencing of mutant p53 attenuates dominantnegative and gainoffunction activities |
|
https://doi.org/10.18632/oncotarget.6634
|
| 5401-5415 |
|
| Circulating microRNAbased screening tool for breast cancer |
|
https://doi.org/10.18632/oncotarget.6786
|
| 5416-5428 |
|
| Stratified neutrophiltolymphocyte ratio accurately predict mortality risk in hepatocellular carcinoma patients following curative liver resection |
|
https://doi.org/10.18632/oncotarget.6707
|
| 5429-5439 |
|
| Expression of the FGFR2 mesenchymal splicing variant in epithelial cells drives epithelialmesenchymal transition |
|
https://doi.org/10.18632/oncotarget.6706
|
| 5440-5460 |
|
| Activating <em>JAK1</em> mutation may predict the sensitivity of JAKSTAT inhibition in hepatocellular carcinoma |
|
https://doi.org/10.18632/oncotarget.6684
|
| 5461-5469 |
|
| Chronic NFκB activation links COPD and lung cancer through generation of an immunosuppressive microenvironment in the lungs |
|
https://doi.org/10.18632/oncotarget.6562
|
| 5470-5482 |
|
| Use of a novel cytotoxic HEXIM1 peptide in the directed breast cancer therapy |
|
https://doi.org/10.18632/oncotarget.6794
|
| 5483-5494 |
|
| The identification of two regulatory ESCC susceptibility genetic variants in the TERTCLPTM1L loci |
|
https://doi.org/10.18632/oncotarget.6747
|
| 5495-5506 |
|
| CD69 expression potentially predicts response to bendamustine and its modulation by ibrutinib or idelalisib enhances cytotoxic effect in chronic lymphocytic leukemia |
|
https://doi.org/10.18632/oncotarget.6685
|
| 5507-5520 |
|
| Reversal of the glycolytic phenotype of primary effusion lymphoma cells by combined targeting of cellular metabolism and PI3K/Akt/ mTOR signaling |
|
https://doi.org/10.18632/oncotarget.6315
|
| 5521-5537 |
|
| Somatostatin Analogues according to Ki67 index in neuroendocrine tumours: an observational retrospectiveprospective analysis from real life |
|
https://doi.org/10.18632/oncotarget.6686
|
| 5538-5547 |
|
| Clusterin induced by NN’Dinitrosopiperazine is involved in nasopharyngeal carcinoma metastasis |
|
https://doi.org/10.18632/oncotarget.6750
|
| 5548-5563 |
|
| Clinical prognostic significance and prometastatic activity of RANK/RANKL via the AKT pathway in endometrial cancer |
|
https://doi.org/10.18632/oncotarget.6795
|
| 5564-5575 |
|
| HER3 targeting alters the dimerization pattern of ErbB protein family members in breast carcinomas |
|
https://doi.org/10.18632/oncotarget.6762
|
| 5576-5597 |
|
| Targeting the Warburg effect in cancer cells through ENO1 knockdown rescues oxidative phosphorylation and induces growth arrest |
|
https://doi.org/10.18632/oncotarget.6798
|
| 5598-5612 |
|
| CD147 regulates cancer migration via direct interaction with Annexin A2 and DOCK3βcateninWAVE2 signaling |
|
https://doi.org/10.18632/oncotarget.6723
|
| 5613-5629 |
|
| The cytomegalovirus protein UL138 induces apoptosis of gastric cancer cells by binding to heat shock protein 70 |
|
https://doi.org/10.18632/oncotarget.6800
|
| 5630-5645 |
|
| Combating autophagy is a strategy to increase cytotoxic effects of novel ALK inhibitor entrectinib in neuroblastoma cells |
|
https://doi.org/10.18632/oncotarget.6778
|
| 5646-5663 |
|
| A tyrosine phosphatase SHP2 gainoffunction mutation enhances malignancy of breast carcinoma |
|
https://doi.org/10.18632/oncotarget.6561
|
| 5664-5676 |
|
| Kaiso a transcriptional repressor promotes cell migration and invasion of prostate cancer cells through regulation of miR31 expression |
|
https://doi.org/10.18632/oncotarget.6801
|
| 5677-5689 |
|
| Downregulation of the zincfinger homeobox protein TSHZ2 releases GLI1 from the nuclear repressor complex to restore its transcriptional activity during mammary tumorigenesis |
|
https://doi.org/10.18632/oncotarget.6788
|
| 5690-5701 |
|
| Micro RNA 100 sensitizes luminal A breast cancer cells to paclitaxel treatment in part by targeting mTOR |
|
https://doi.org/10.18632/oncotarget.6790
|
| 5702-5714 |
|
| Wogonin inhibits multiple myelomastimulated angiogenesis via cMyc/VHL/HIF1α signaling axis |
|
https://doi.org/10.18632/oncotarget.6796
|
| 5715-5727 |
|
| Increased levels of lowdensity lipoprotein cholesterol within the normal range as a risk factor for nonalcoholic fatty liver disease |
|
https://doi.org/10.18632/oncotarget.6799
|
| 5728-5737 |
|
| LKB1 acts as a critical gatekeeper of ovarian primordial follicle pool |
|
https://doi.org/10.18632/oncotarget.6792
|
| 5738-5753 |
|
| Notch and Wnt/βcatenin signaling pathway play important roles in activating liver cancer stem cells |
|
https://doi.org/10.18632/oncotarget.6805
|
| 5754-5768 |
|
| A MALAT1/HIF2α feedback loop contributes to arsenite carcinogenesis |
|
https://doi.org/10.18632/oncotarget.6806
|
| 5769-5787 |
|
| Induction of autophagy promotes the growth of early preneoplastic rat liver nodules |
|
https://doi.org/10.18632/oncotarget.6810
|
| 5788-5799 |
|
| RPS7 inhibits colorectal cancer growth via decreasing HIF1αmediated glycolysis |
|
https://doi.org/10.18632/oncotarget.6807
|
| 5800-5814 |
|
| Metabolomic profile in pancreatic cancer patients: a consensusbased approach to identify highly discriminating metabolites |
|
https://doi.org/10.18632/oncotarget.6808
|
| 5815-5829 |
|
| Characterization of the novel tumorsuppressor gene CCDC67 in papillary thyroid carcinoma |
|
https://doi.org/10.18632/oncotarget.6709
|
| 5830-5841 |
|
| RASSF1A inhibits gastric cancer cell proliferation by miR711 mediated downregulation of CDK4 expression |
|
https://doi.org/10.18632/oncotarget.6813
|
| 5842-5851 |
|
| Comprehensive mapping of the human papillomavirus HPV DNA integration sites in cervical carcinomas by HPV capture technology |
|
https://doi.org/10.18632/oncotarget.6809
|
| 5852-5864 |
|
| Type 2 diabetesinduced neuronal pathology in the piriform cortex of the rat is reversed by the GLP1 receptor agonist exendin4 |
|
https://doi.org/10.18632/oncotarget.6823
|
| 5865-5876 |
|
| Tea nanoparticle a safe and biocompatible nanocarrier greatly potentiates the anticancer activity of doxorubicin |
|
https://doi.org/10.18632/oncotarget.6711
|
| 5877-5891 |
|
| Gastroduodenal fluid induced nuclear factor<em>κappa</em>B activation and early premalignant alterations in murine hypopharyngeal mucosa |
|
https://doi.org/10.18632/oncotarget.6824
|
| 5892-5908 |
|
| Integrative bioinformatic analyses of an oncogenomic profile reveal the biology of endometrial cancer and guide drug discovery |
|
https://doi.org/10.18632/oncotarget.6716
|
| 5909-5923 |
|
| N3oxoacyl homoserine lactone inhibits tumor growth independent of Bcl2 proteins |
|
https://doi.org/10.18632/oncotarget.6827
|
| 5924-5942 |
|
| Serum CA125 is a novel predictive marker for pancreatic cancer metastasis and correlates with the metastasisassociated burden |
|
https://doi.org/10.18632/oncotarget.6819
|
| 5943-5956 |
|
| The role of the obestatin/GPR39 system in human gastric adenocarcinomas |
|
https://doi.org/10.18632/oncotarget.6718
|
| 5957-5971 |
|
| MiRlet7a inhibits cell proliferation migration and invasion by downregulating PKM2 in gastric cancer |
|
https://doi.org/10.18632/oncotarget.6821
|
| 5972-5984 |
|
| Synergistic effect of therapeutic stem cells expressing cytosine deaminase and interferonbeta via apoptotic pathway in the metastatic mouse model of breast cancer |
|
https://doi.org/10.18632/oncotarget.6719
|
| 5985-5999 |
|
| Hypoxiainduced lncRNANUTF2P3001 contributes to tumorigenesis of pancreatic cancer by derepressing the miR3923/KRAS pathway |
|
https://doi.org/10.18632/oncotarget.6830
|
| 6000-6014 |
|
| BAY 1024767 blocks androgen receptor mutants found in castrationresistant prostate cancer patients |
|
https://doi.org/10.18632/oncotarget.6864
|
| 6015-6028 |
|
| Quantum dots implementation as a label for analysis of early stages of EGF receptor endocytosis: a comparative study on cultured cells |
|
https://doi.org/10.18632/oncotarget.6720
|
| 6029-6047 |
|
| Axon guidance molecule semaphorin3A is a novel tumor suppressor in head and neck squamous cell carcinoma |
|
https://doi.org/10.18632/oncotarget.6831
|
| 6048-6062 |
|
| The prognostic value of age for invasive lobular breast cancer depending on estrogen receptor and progesterone receptordefined subtypes: A NCDB analysis |
|
https://doi.org/10.18632/oncotarget.5844
|
| 6063-6073 |
|
| Lanatoside C suppressed colorectal cancer cell growth by inducing mitochondrial dysfunction and increased radiation sensitivity by impairing DNA damage repair |
|
https://doi.org/10.18632/oncotarget.6832
|
| 6074-6087 |
|
| Inhibition of endothelial Cdk5 reduces tumor growth by promoting nonproductive angiogenesis |
|
https://doi.org/10.18632/oncotarget.6842
|
| 6088-6104 |
|
| Thrombospondin1 might be a therapeutic target to suppress RB cells by regulating the DNA doublestrand breaks repair |
|
https://doi.org/10.18632/oncotarget.6835
|
| 6105-6120 |
|
| Preferential expression of functional IL17R in glioma stem cells: potential role in selfrenewal |
|
https://doi.org/10.18632/oncotarget.6847
|
| 6121-6135 |
|
| Trop2 is overexpressed in gastric cancer and predicts poor prognosis |
|
https://doi.org/10.18632/oncotarget.6733
|
| 6136-6145 |
|
| Proteome profiling of cadmiuminduced apoptosis by antibody array analyses in human bronchial epithelial cells |
|
https://doi.org/10.18632/oncotarget.6738
|
| 6146-6158 |
|
| A subset of myofibroblastic cancerassociated fibroblasts regulate collagen fiber elongation which is prognostic in multiple cancers |
|
https://doi.org/10.18632/oncotarget.6740
|
| 6159-6174 |
|
| FZD7 regulates BMSCsmediated protection of CML cells |
|
https://doi.org/10.18632/oncotarget.6742
|
| 6175-6187 |
|
| Negative regulation of Bmi1 by AMPK and implication in cancer progression |
|
https://doi.org/10.18632/oncotarget.6748
|
| 6188-6200 |
|
| Mutations in PI3K/AKT pathway genes and amplifications of <i>PIK3CA</i> are associated with patterns of recurrence in gastric cancers |
|
https://doi.org/10.18632/oncotarget.6641
|
| 6201-6220 |
|
| Plasma EpsteinBarr viral DNA complements TNM classification of nasopharyngeal carcinoma in the era of intensitymodulated radiotherapy |
|
https://doi.org/10.18632/oncotarget.6754
|
| 6221-6230 |
|
| Antitumoral effect of Ocoxin on acute myeloid leukemia |
|
https://doi.org/10.18632/oncotarget.6862
|
| 6231-6242 |
|
| The significance of Brf1 overexpression in human hepatocellular carcinoma |
|
https://doi.org/10.18632/oncotarget.6668
|
| 6243-6254 |
|
| Fast clearance of lipid droplets through MAP1Sactivated autophagy suppresses clear cell renal cell carcinomas and promotes patient survival |
|
https://doi.org/10.18632/oncotarget.6669
|
| 6255-6265 |
|
| Maternal embryonic leucine zipper kinase serves as a poor prognosis marker and therapeutic target in gastric cancer |
|
https://doi.org/10.18632/oncotarget.6673
|
| 6266-6280 |
|
| Ki67 is required for maintenance of cancer stem cells but not cell proliferation |
|
https://doi.org/10.18632/oncotarget.7057
|
| 6281-6293 |
|
| PDIP46 DNA polymerase δ interacting protein 46 is an activating factor for human DNA polymerase δ |
|
https://doi.org/10.18632/oncotarget.7034
|
| 6294-6313 |
|
| Generation and characterization of a tetraspanin CD151/integrin α6β1binding domain competitively binding monoclonal antibody for inhibition of tumor progression in HCC |
|
https://doi.org/10.18632/oncotarget.6833
|
| 6314-6322 |
Clinical Research Papers
|
| Decreased TPD52 expression is associated with poor prognosis in primary hepatocellular carcinoma |
|
https://doi.org/10.18632/oncotarget.6319
|
| 6323-6334 |
|
| Tumor deposits: markers of poor prognosis in patients with locally advanced rectal cancer following neoadjuvant chemoradiotherapy |
|
https://doi.org/10.18632/oncotarget.6656
|
| 6335-6344 |
|
| Dosimetric comparisons of VMAT IMRT and 3DCRT for locally advanced rectal cancer with simultaneous integrated boost |
|
https://doi.org/10.18632/oncotarget.6401
|
| 6345-6351 |
Corrections
|
| Correction: Individualized strategies to target specific mechanisms of disease in malignant melanoma patients displaying unique mutational signatures |
|
https://doi.org/10.18632/oncotarget.7118
|
| 6352 |
Copyright © 2026 Rapamycin Press LLC dba Impact Journals
Oncotarget ® is a registered trademark of Rapamycin Press LLC
Impact Journals ® is a registered trademark of Rapamycin Press LLC
RAPAMYCIN PRESS ® is a registered trademark of Rapamycin Press LLCß
